Polen Capital Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.3M Sell
178,669
-823,237
-82% -$56.8M 0.04% 43
2025
Q1
$69.6M Sell
1,001,906
-5,403,842
-84% -$375M 0.22% 33
2024
Q4
$551M Sell
6,405,748
-448,911
-7% -$38.6M 1.49% 22
2024
Q3
$816M Sell
6,854,659
-593,313
-8% -$70.6M 2.11% 20
2024
Q2
$1.06B Sell
7,447,972
-320,807
-4% -$45.8M 2.67% 16
2024
Q1
$998M Sell
7,768,779
-189,665
-2% -$24.4M 2.3% 18
2023
Q4
$823M Buy
7,958,444
+52,189
+0.7% +$5.4M 1.98% 19
2023
Q3
$719M Buy
+7,906,255
New +$719M 1.89% 19
2020
Q1
Sell
-237,618
Closed -$6.88M 68
2019
Q4
$6.88M Buy
237,618
+99,320
+72% +$2.87M 0.03% 32
2019
Q3
$3.58M Buy
138,298
+19,612
+17% +$507K 0.02% 31
2019
Q2
$3.03M Buy
118,686
+26,776
+29% +$683K 0.01% 29
2019
Q1
$2.4M Buy
91,910
+28,470
+45% +$745K 0.01% 30
2018
Q4
$1.46M Buy
63,440
+11,940
+23% +$275K 0.01% 30
2018
Q3
$1.21M Buy
51,500
+2,462
+5% +$58K 0.01% 31
2018
Q2
$1.13M Buy
49,038
+4,172
+9% +$96.2K 0.01% 29
2018
Q1
$1.11M Buy
44,866
+7,428
+20% +$183K 0.01% 29
2017
Q4
$1.01M Buy
37,438
+2,388
+7% +$64.1K 0.01% 31
2017
Q3
$844K Buy
35,050
+1,744
+5% +$42K 0.01% 29
2017
Q2
$714K Sell
33,306
-480
-1% -$10.3K 0.01% 26
2017
Q1
$579K Buy
33,786
+2,254
+7% +$38.6K 0.01% 26
2016
Q4
$565K Buy
31,532
+3,432
+12% +$61.5K 0.01% 26
2016
Q3
$584K Buy
28,100
+3,772
+16% +$78.4K 0.01% 27
2016
Q2
$654K Buy
24,328
+8,864
+57% +$238K 0.01% 26
2016
Q1
$419K Buy
15,464
+2,466
+19% +$66.8K 0.01% 27
2015
Q4
$377K Buy
+12,998
New +$377K 0.01% 26
2013
Q3
Sell
-22,580
Closed -$350K 27
2013
Q2
$350K Buy
+22,580
New +$350K 0.01% 25